Professional Documents
Culture Documents
Benign Ovarian Tumours
Benign Ovarian Tumours
Benign Ovarian Tumours
TUMOURS
SEMINAR 11
GROUP MEMBERS
Nulliparity
Intrauterine
Endometriosis
Obesity
Types of Benign Ovarian Cyst
FUNCTIONAL CYSTS(FOLLICULAR CYST)
Diagnosis
❏ Pelvic ultrasound
INFLAMMATORY CYSTS (TUBO-OVARIAN
ABSCESS)
● Tubo-ovarian abscess (TOA) is a recognized and serious
complication of untreated pelvic inflammatory disease
(PID).
● It most commonly affects women of reproductive age
and nearly 60% of women with TOA are nulliparous.
● TOA is defined as an inflammatory mass involving the
tube and/or ovary characterized by the presence of pus.
● The most common cause is ascending/upper genital
tract infection when purulent material can discharge
through the tube directly into the peritoneal cavity
causing initial PID and progression to form a TOA.
● TOA carries a high morbidity and can be life threatening.
● Symptoms and signs TOA :
○ Adnexal tenderness (bilateral or unilateral)
○ Cervical excitation
○ Abnormal cervical or vaginal discharge
● Diagnosis:
❏ Increased WBC, Inflammatory marker (high CRP and
ESR)
❏ Ultrasound ,laparoscopy
● Treatment
❏ Antibiotics (IV clindamycin, IV metronidazole and IV
cefoxitin), surgical drainage and excision.
● Potential long-term consequences of a TOA includes
infertility, an increased risk of ectopic pregnancy and chronic
pelvic pain.
INFLAMMATORY CYSTS (ENDOMETRIOMA)
◦ This cyst may be large and contains old, altered blood that
has a thick brown appearance and it is frequently referred to
as a ‘chocolate cyst’.
◦Treatment
❏ NSAIDS,COCP, Progestins, GnRH agonist,
laparoscopic drainage and excision
DERMOID CYST (MATURE CYSTIC TERATOMA)
◦It is the most common ovarian tumors in young women aged 20–40
years, accounting for more than 50% of ovarian tumors in this age
group with a peak incidence in the early 20s.
◦It contains fully differentiated tissue types derived from all three
embryonic germ cell layers (mesenchymal, epithelial and stroma).
◦Dermoid cyst is usually full of sebaceous material and hair but may
contain teeth, skin, cartilage, fat, or bone.
◦Up to 10% of dermoid cysts are bilateral, seldom large and often
asymptomatic. But large tumors may cause increase abdominal girth
and lower abdominal pain.
◦Complications :
a) Leakage or spillage of dermoid cyst contents can cause chemical peritonitis
b) Ovarian torsion
c) The risk of malignant transformation is rare (<2%) usually occurring in
women over 40 years.
◦Diagnosis
❏ It is usually confirmed with a pelvic USS and
because of the high fat content present in
dermoid cysts, MRI may also be useful where
there is uncertainty.
◦Management
❏ Ovarian cystectomy is indicated because
spontaneous resolution is unlikely
❏ Cystectomy will prevent ovarian torsion and
provide tissue for histological analysis.
Serous Cystadenoma
Characteristics
● Greater than 1 cm
Definition ● Benign, Asymptomatic
● Serous cystadenoma is a non-cancerous ovarian ● Unilocular and multilocular cysts
tumor made up of fluid-filled cysts. Pelvic Discomfort (due to the pressure)
● Affects women of reproductive age. Clinical Features
● Measures more than 1 cm in size. ● Abdominal Distension
● Composed of cells resembling of epithelium of ● Palpable Abdominal Mass
fallopian tube and epithelium of ovary. ● Menstrual Irregularities
● Urinary Symptoms (increased frequency, urgency,
or difficulty in emptying the bladder)
CT
Radiological ● Often seen as a unilocular (typically) or
Findings multilocular cystic mass with a thin
Ultrasound regular wall or septum.
● Cysts can be quite large in size and have
● Usually seen as a unilocular
the potential to be seen filling most of the
cystic/anechoic adnexal lesion
lower pelvis with extension into the upper
● Papillary projections are absent
abdomen.
● it is thin, with an acute angle
with the cyst wall and has a
regular surface.
MRI
● The typical MR imaging appearance of
serous cystadenoma is a unilocular thin-
walled adnexal cyst.
● MRI may show a beak sign which may
suggest an ovarian origin.
Complications
1. Torsion: Risk of ovarian twisting leading to reduced blood supply and tissue damage.
2. Rupture: Potential for sudden abdominal pain, internal bleeding, and peritonitis.
3. Pressure Symptoms: Compression of nearby organs causing urinary, bowel, or
abdominal discomfort.
4. Malignant Transformation: Rare chance of developing borderline or malignant features
requiring further evaluation and treatment.
5. Impact on Fertility: Large or bilateral cysts may affect ovarian function and fertility.
6. Recurrence: Small possibility of cysts returning after surgical removal.
Management
● Symptom Management: Pain management or hormonal
therapy (such as oral contraceptives)
● Surgical Intervention: Surgical removal of the serous
cystadenoma may be necessary. Surgical options include
cystectomy (removal of the cyst while preserving the
ovary), oophorectomy (removal of the affected ovary), or
salpingo-oophorectomy (removal of the affected ovary
and fallopian tube).
● Unilateral salpingo-oophorectomy or ovarian cystectomy
is the adequate treatment of ovarian cystadenomas.
Mucinous Cystadenoma
Clinical Features
1. Large abdominal mass or swelling
2. Pelvic pain or discomfort
3. Abdominal distension or bloating
4. Changes in bowel habits, such as constipation or diarrhea
5. Urinary urgency or frequency
6. Menstrual irregularities or abnormal vaginal bleeding
7. Ascites
Radiological findings
Ultrasound MRI
Characteristics
1. Benign Brenner tumor: Adenofibromatous architecture with nests of bland transitional epithelium
present within fibromatous stroma.
2. Borderline Brenner tumor: Papillary architecture with papillae covered by multilayered transitional
epithelium.
3. Malignant Brenner tumor: Stromal invasion by carcinoma with transitional cell features.
Clinical features
1. Benign Brenner tumors are
Complications
usually asymptomatic 1. Complications of Brenner
Radiological findings
1. Radiological findings for Brenner tumors include Management
solid, well-defined masses on imaging studies such as 1. Oophorectomy
ultrasound, CT, or MRI. They can appear hypoechoic 2. No adjuvant treatment for benign or borderline Brenner
or isoechoic on ultrasound, have low attenuation on tumors
CT with calcifications, and show low signal intensity 3. Adjuvant chemotherapy for advanced stage malignant
on MRI. Brenner tumors.
Fibroma
Definition Clinical features
A fibroma is a type of benign stromal
1. Symptoms of ovarian fibromas may include abdominal
tumor that consists of fibroblastic cells
pain, distension, and increased urinary frequency.
embedded within a stroma that contains
2. Ovarian torsion
varying amounts of collagen.
3. Large ovarian fibromas (> 10 cm) may cause ascites.
4. Sometimes may lead to misdiagnosis, as calcified uterine
Characteristics leiomyoma.
5. Renin-secreting ovarian fibromas can lead to gestational
1. Benign stromal tumor
hypertension.
2. Found in women who are in
6. Recurrence of ovarian fibromas is possible.
perimenopause or post menopause
3. Composed of spindled, ovoid to round cells
Radiological Findings
1. solid, well-defined tumors that can vary in 3. Some women with thecomas may experience pelvic
Management
● Oophorectomy if fertility sparing is desired
● Total hysterectomy with bilateral salpingo-oophorectomy is indicated in postmenopausal patients
https://www.youtube.com/watch?v=PeL-5GV5GUA
Staging
Tumor Markers
Screening Of Benign Ovarian tumor
❏ Women who test positive for BRCA mutation can be offered risk reducing
prophylactic BSO when they have completed their family.
❏ Prophylactic surgery reduces the risk of ovarian cancer by 90%
❏ Performing bilateral salpingectomy with delayed oophorectomy in the 30s
and early 40s may offset the morbidity associated with a surgical
menopause in young women while reducing the risk of cancer
❏ Recent data indicates that the opportunistic removal of the Fallopian
tubes during hysterectomy for benign indications also reduces ovarian
cancer risk in women at average lifetime risk of ovarian cancer.
❏ Chemoprevention using COCP reduces ovarian cancer risk by up to 50%
in both BRCA mutation carriers and women at average risk of ovarian
cancer.
References